Microfluidics, with its remarkable capacity to manipulate fluids and droplets at the
microscale, has emerged as a powerful platform in numerous fields. In contrast to …

Adjuvants are of critical value in vaccine development as they act on enhancing
immunogenicity of antigen and inducing long‐lasting immunity. However, there are only a …

Nanomedicine is a new discipline resulting from the combination of nanotechnology and
biomedicine. Nanomedicine has contributed to the development of new and improved …

Influenza is a global health concern with millions of infections occurring yearly. Seasonal flu
vaccines are one way to combat this virus; however, they are poorly protective against …

The most common influenza vaccines are inactivated viruses produced in chicken eggs,
which is a time-consuming production method with variable efficacy due to mismatches of …

The influenza A virus causes substantial morbidity and mortality worldwide every year and
poses a constant threat of an emergent pandemic. Seasonal influenza vaccination strategies …

A subunit or protein-based influenza vaccine can be a safer alternative to live attenuated
vaccine (Flumist) and require fewer boosts than an inactivated vaccine (eg Fluzone) …

Particles of interest in food, pharmaceutical, and nutraceutical sectors are often formulated
with a polymer and one or more natural or synthetic active compound. The two components …

Influenza viruses cause a common respiratory disease known as influenza. In humans,
seasonal influenza viruses can lead to epidemics, with avian influenza viruses of particular …

Rapamycin (rapa), an immunosuppressive medication, has demonstrated considerable
effectiveness in reducing organ transplant rejection and treating select autoimmune …